U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: over 10,000 records

Showing results for "years".

  1. ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - some stroke) Cardiovascular Disease (2) Leading killer Huge declines in CVD death in the past 20 years … , and are willing to take low-dose aspirin daily for at least 10 years. … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … ar1e willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … and harms of aspirin use to prevent CVD and colorectal cancer in adults younger than age 50 years.

  2. ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD

    pbrn.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - some stroke) Cardiovascular Disease (2) Leading killer Huge declines in CVD death in the past 20 years … , and are willing to take low-dose aspirin daily for at least 10 years. … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … ar1e willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … and harms of aspirin use to prevent CVD and colorectal cancer in adults younger than age 50 years.

  3. ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD

    pcmh.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - some stroke) Cardiovascular Disease (2) Leading killer Huge declines in CVD death in the past 20 years … , and are willing to take low-dose aspirin daily for at least 10 years. … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … ar1e willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … and harms of aspirin use to prevent CVD and colorectal cancer in adults younger than age 50 years.

  4. ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD

    healthcare411.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - some stroke) Cardiovascular Disease (2) Leading killer Huge declines in CVD death in the past 20 years … , and are willing to take low-dose aspirin daily for at least 10 years. … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … ar1e willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … and harms of aspirin use to prevent CVD and colorectal cancer in adults younger than age 50 years.

  5. ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD

    cahps.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - some stroke) Cardiovascular Disease (2) Leading killer Huge declines in CVD death in the past 20 years … , and are willing to take low-dose aspirin daily for at least 10 years. … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … ar1e willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … and harms of aspirin use to prevent CVD and colorectal cancer in adults younger than age 50 years.

  6. ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD

    monahrq.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - some stroke) Cardiovascular Disease (2) Leading killer Huge declines in CVD death in the past 20 years … , and are willing to take low-dose aspirin daily for at least 10 years. … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … ar1e willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … and harms of aspirin use to prevent CVD and colorectal cancer in adults younger than age 50 years.

  7. ABCS Aspirin Treatment for Secondary and Primary Prevention ASCVD

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/evidencenow/heart-health/aspirin-asa-measure.pptx
    April 01, 2016 - some stroke) Cardiovascular Disease (2) Leading killer Huge declines in CVD death in the past 20 years … , and are willing to take low-dose aspirin daily for at least 10 years. … Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and … ar1e willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. … and harms of aspirin use to prevent CVD and colorectal cancer in adults younger than age 50 years.

  8. CHIPRA 155: Section 6.B, Scientific Soundness of the Measure (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-6-b-measure.pdf
    January 01, 2013 - Ref. 6-12 years old / 0.779d 0.783d 0.729d 0.765d 0.765d 0.764d 1-5 years old / 0.639d 0.643d 0.561d … Ref. 6-12 years old / 0.502d 0.502d 0.513d 0.485d 0.485d 0.486d 1-5 years old / 0.969 0.968 1.008 … Ref. 6-12 years old / 0.457d 0.457d 0.459d 0.423d 0.424d 0.425d 1-5 years old / 0.976 0.976 0.973 … Ref. 6-12 years old / 0.461d 0.461d 0.462d 0.389d 0.390d 0.390d 1-5 years old / 0.970 0.970 0.976 … Ref. 6-12 years old / 0.432d 0.432d 0.429d 0.452a 0.452d 0.459d 1-5 years old / 1.037 1.037 1.023

  9. CHIPRA 155: Section 6.B, Scientific Soundness of the Measure (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-6-b-measure.pdf
    January 01, 2013 - Ref. 6-12 years old / 0.779d 0.783d 0.729d 0.765d 0.765d 0.764d 1-5 years old / 0.639d 0.643d 0.561d … Ref. 6-12 years old / 0.502d 0.502d 0.513d 0.485d 0.485d 0.486d 1-5 years old / 0.969 0.968 1.008 … Ref. 6-12 years old / 0.457d 0.457d 0.459d 0.423d 0.424d 0.425d 1-5 years old / 0.976 0.976 0.973 … Ref. 6-12 years old / 0.461d 0.461d 0.462d 0.389d 0.390d 0.390d 1-5 years old / 0.970 0.970 0.976 … Ref. 6-12 years old / 0.432d 0.432d 0.429d 0.452a 0.452d 0.459d 1-5 years old / 1.037 1.037 1.023

  10. CHIPRA 155: Section 6.B, Scientific Soundness of the Measure (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-6-b-measure.pdf
    January 01, 2013 - Ref. 6-12 years old / 0.779d 0.783d 0.729d 0.765d 0.765d 0.764d 1-5 years old / 0.639d 0.643d 0.561d … Ref. 6-12 years old / 0.502d 0.502d 0.513d 0.485d 0.485d 0.486d 1-5 years old / 0.969 0.968 1.008 … Ref. 6-12 years old / 0.457d 0.457d 0.459d 0.423d 0.424d 0.425d 1-5 years old / 0.976 0.976 0.973 … Ref. 6-12 years old / 0.461d 0.461d 0.462d 0.389d 0.390d 0.390d 1-5 years old / 0.970 0.970 0.976 … Ref. 6-12 years old / 0.432d 0.432d 0.429d 0.452a 0.452d 0.459d 1-5 years old / 1.037 1.037 1.023

  11. CHIPRA 155: Section 6.B, Scientific Soundness of the Measure (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-6-b-measure.pdf
    January 01, 2013 - Ref. 6-12 years old / 0.779d 0.783d 0.729d 0.765d 0.765d 0.764d 1-5 years old / 0.639d 0.643d 0.561d … Ref. 6-12 years old / 0.502d 0.502d 0.513d 0.485d 0.485d 0.486d 1-5 years old / 0.969 0.968 1.008 … Ref. 6-12 years old / 0.457d 0.457d 0.459d 0.423d 0.424d 0.425d 1-5 years old / 0.976 0.976 0.973 … Ref. 6-12 years old / 0.461d 0.461d 0.462d 0.389d 0.390d 0.390d 1-5 years old / 0.970 0.970 0.976 … Ref. 6-12 years old / 0.432d 0.432d 0.429d 0.452a 0.452d 0.459d 1-5 years old / 1.037 1.037 1.023

  12. CHIPRA 155: Section 6.B, Scientific Soundness of the Measure (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-6-b-measure.pdf
    January 01, 2013 - Ref. 6-12 years old / 0.779d 0.783d 0.729d 0.765d 0.765d 0.764d 1-5 years old / 0.639d 0.643d 0.561d … Ref. 6-12 years old / 0.502d 0.502d 0.513d 0.485d 0.485d 0.486d 1-5 years old / 0.969 0.968 1.008 … Ref. 6-12 years old / 0.457d 0.457d 0.459d 0.423d 0.424d 0.425d 1-5 years old / 0.976 0.976 0.973 … Ref. 6-12 years old / 0.461d 0.461d 0.462d 0.389d 0.390d 0.390d 1-5 years old / 0.970 0.970 0.976 … Ref. 6-12 years old / 0.432d 0.432d 0.429d 0.452a 0.452d 0.459d 1-5 years old / 1.037 1.037 1.023

  13. CHIPRA 155: Section 6.B, Scientific Soundness of the Measure (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-6-b-measure.pdf
    January 01, 2013 - Ref. 6-12 years old / 0.779d 0.783d 0.729d 0.765d 0.765d 0.764d 1-5 years old / 0.639d 0.643d 0.561d … Ref. 6-12 years old / 0.502d 0.502d 0.513d 0.485d 0.485d 0.486d 1-5 years old / 0.969 0.968 1.008 … Ref. 6-12 years old / 0.457d 0.457d 0.459d 0.423d 0.424d 0.425d 1-5 years old / 0.976 0.976 0.973 … Ref. 6-12 years old / 0.461d 0.461d 0.462d 0.389d 0.390d 0.390d 1-5 years old / 0.970 0.970 0.976 … Ref. 6-12 years old / 0.432d 0.432d 0.429d 0.452a 0.452d 0.459d 1-5 years old / 1.037 1.037 1.023

  14. Attachments 6.1 through 6.9 (pdf file)

    www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
    March 01, 2011 - DESCRIPTION Percentage of patients aged 4 through 18 years with a diagnosis of Attention Deficit Hyperactivity … 2,097 22.8% 18 0.2% 3 0.0% 4-18 years 3,114,809 100% 1,614,857 52% 58,528 3.62% 47,920 2.97% 9,186 … 649,522 13-18 years 1,064,132 533,850 481,935 415,127 359,310 326,717 4-18 years 3,105,806 1,755,481 … Commercial 2010-2011 4-5 years 1,767,905 922,570 874,406 802,688 745,524 717,715 6-12 years 6,635,306 … years 3,105,806 1,614,146 91,240 75,391 58,448 9,575 5,983 2,922 1,694 1b.

  15. Attachments 6.1 through 6.9 (pdf file)

    www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
    March 01, 2011 - DESCRIPTION Percentage of patients aged 4 through 18 years with a diagnosis of Attention Deficit Hyperactivity … 2,097 22.8% 18 0.2% 3 0.0% 4-18 years 3,114,809 100% 1,614,857 52% 58,528 3.62% 47,920 2.97% 9,186 … 649,522 13-18 years 1,064,132 533,850 481,935 415,127 359,310 326,717 4-18 years 3,105,806 1,755,481 … Commercial 2010-2011 4-5 years 1,767,905 922,570 874,406 802,688 745,524 717,715 6-12 years 6,635,306 … years 3,105,806 1,614,146 91,240 75,391 58,448 9,575 5,983 2,922 1,694 1b.

  16. Attachments 6.1 through 6.9 (pdf file)

    www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
    March 01, 2011 - DESCRIPTION Percentage of patients aged 4 through 18 years with a diagnosis of Attention Deficit Hyperactivity … 2,097 22.8% 18 0.2% 3 0.0% 4-18 years 3,114,809 100% 1,614,857 52% 58,528 3.62% 47,920 2.97% 9,186 … 649,522 13-18 years 1,064,132 533,850 481,935 415,127 359,310 326,717 4-18 years 3,105,806 1,755,481 … Commercial 2010-2011 4-5 years 1,767,905 922,570 874,406 802,688 745,524 717,715 6-12 years 6,635,306 … years 3,105,806 1,614,146 91,240 75,391 58,448 9,575 5,983 2,922 1,694 1b.

  17. Attachments 6.1 through 6.9 (pdf file)

    www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
    March 01, 2011 - DESCRIPTION Percentage of patients aged 4 through 18 years with a diagnosis of Attention Deficit Hyperactivity … 2,097 22.8% 18 0.2% 3 0.0% 4-18 years 3,114,809 100% 1,614,857 52% 58,528 3.62% 47,920 2.97% 9,186 … 649,522 13-18 years 1,064,132 533,850 481,935 415,127 359,310 326,717 4-18 years 3,105,806 1,755,481 … Commercial 2010-2011 4-5 years 1,767,905 922,570 874,406 802,688 745,524 717,715 6-12 years 6,635,306 … years 3,105,806 1,614,146 91,240 75,391 58,448 9,575 5,983 2,922 1,694 1b.

  18. Attachments 6.1 through 6.9 (pdf file)

    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
    March 01, 2011 - DESCRIPTION Percentage of patients aged 4 through 18 years with a diagnosis of Attention Deficit Hyperactivity … 2,097 22.8% 18 0.2% 3 0.0% 4-18 years 3,114,809 100% 1,614,857 52% 58,528 3.62% 47,920 2.97% 9,186 … 649,522 13-18 years 1,064,132 533,850 481,935 415,127 359,310 326,717 4-18 years 3,105,806 1,755,481 … Commercial 2010-2011 4-5 years 1,767,905 922,570 874,406 802,688 745,524 717,715 6-12 years 6,635,306 … years 3,105,806 1,614,146 91,240 75,391 58,448 9,575 5,983 2,922 1,694 1b.

  19. Attachments 6.1 through 6.9 (pdf file)

    www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
    March 01, 2011 - DESCRIPTION Percentage of patients aged 4 through 18 years with a diagnosis of Attention Deficit Hyperactivity … 2,097 22.8% 18 0.2% 3 0.0% 4-18 years 3,114,809 100% 1,614,857 52% 58,528 3.62% 47,920 2.97% 9,186 … 649,522 13-18 years 1,064,132 533,850 481,935 415,127 359,310 326,717 4-18 years 3,105,806 1,755,481 … Commercial 2010-2011 4-5 years 1,767,905 922,570 874,406 802,688 745,524 717,715 6-12 years 6,635,306 … years 3,105,806 1,614,146 91,240 75,391 58,448 9,575 5,983 2,922 1,694 1b.

  20. Attachments 6.1 through 6.9 (pdf file)

    ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-vi-a.pdf
    March 01, 2011 - DESCRIPTION Percentage of patients aged 4 through 18 years with a diagnosis of Attention Deficit Hyperactivity … 2,097 22.8% 18 0.2% 3 0.0% 4-18 years 3,114,809 100% 1,614,857 52% 58,528 3.62% 47,920 2.97% 9,186 … 649,522 13-18 years 1,064,132 533,850 481,935 415,127 359,310 326,717 4-18 years 3,105,806 1,755,481 … Commercial 2010-2011 4-5 years 1,767,905 922,570 874,406 802,688 745,524 717,715 6-12 years 6,635,306 … years 3,105,806 1,614,146 91,240 75,391 58,448 9,575 5,983 2,922 1,694 1b.
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (8212)

www.ahrq.gov (6211)

effectivehealthcare-admin.ahrq.gov (4508)

ce.effectivehealthcare.ahrq.gov (3705)

digital.ahrq.gov (3329)

hcup-us.ahrq.gov (2907)

meps.ahrq.gov (2648)

effectivehealthcare.ahrq.gov (2643)

cmext.ahrq.gov (2540)

srdr.ahrq.gov (2248)

www.uspreventiveservicestaskforce.org (2141)

www.qualitymeasures.ahrq.gov (2133)

www.talkingquality.ahrq.gov (1517)

www.monahrq.ahrq.gov (1475)

www.innovations.ahrq.gov (1461)

www.healthcare411.ahrq.gov (1458)

www.cahps.ahrq.gov (1363)

www.cpsi.ahrq.gov (1180)

pbrn.ahrq.gov (999)

cahps.ahrq.gov (997)

pcmh.ahrq.gov (997)

healthcare411.ahrq.gov (990)

monahrq.ahrq.gov (967)

talkingquality.ahrq.gov (836)

patientregistry.ahrq.gov (805)

ahrqpubs.ahrq.gov (784)

teamstepps.ahrq.gov (655)

preventiveservices.ahrq.gov (654)

qualityindicators.ahrq.gov (261)

nhqrnet.ahrq.gov (204)

cdsic.ahrq.gov (164)

cds.ahrq.gov (162)

staging-meps.ahrq.gov (108)

ecareplan.ahrq.gov (102)

cahpsdatabase.ahrq.gov (85)

datatools.ahrq.gov (67)

srdrplus.ahrq.gov (28)

pso.ahrq.gov (18)

info.ahrq.gov (13)

covid-acts.ahrq.gov (10)

hcupnet.ahrq.gov (2)

safetyprogram4hai-prevention.ahrq.gov (2)

www.distributor.hcup-us.ahrq.gov (2)

jamanetwork.com (1)

www.psoppc.org (1)